Fortress Biotech Inc FBIO:NASDAQ

Last Price$0.86NASDAQ Previous Close - Last Trade as of 4:00PM ET 5/13/22

Today's Change+0.06(7.29%)
Bid (Size)$0.90 (11)
Ask (Size)$0.95 (1)
Day Low / High$0.83 - 0.97
Volume695.7 K

Fortress Biotech Starts Mid-Stage Triplex Vaccine Trial in Adults with HIV, Cytomegalovirus

10:56AM ET 12/16/2021 MT Newswires
Fortress Biotech (FBIO) on Thursday said that it has commenced a phase 2 trial to evaluate the safety, efficacy, and immunogenicity of Triplex in eliciting an immune response and reducing cytomegalovirus replication in people with HIV.

Triplex, a modified vaccinia ankara-based vaccine, was developed by cancer treatment and research organization City of Hope, according to the biopharmaceutical firm. Cytomegalovirus is a common herpesvirus infection.

Price: 2.60, Change: -0.03, Percent Change: -1.14